The optimal treatment of thyroid gland function disturbances during pregnancy

Current Pharmaceutical Biotechnology

Volumn 12, Issue 5, 2011, Pages 774-780

  Drews, Krzysztof ^a   Seremak Mrozikiewicz, Agnieszka ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Antithyroid drugs; Hyperthyroidism; Hypothyroidism; Pharmacology; Placental transport; Thyroid hormones

Indexed keywords

ANTITHYROID AGENT; THYROID HORMONE;

ARTICLE; EUTHYROIDISM; FERTILIZATION; FETUS DISEASE; FETUS MALFORMATION; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LACTATION; LOW BIRTH WEIGHT; MATERNAL MORBIDITY; MENTAL DEFICIENCY; NEUROLOGIC DISEASE; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PREMATURE LABOR; RECURRENT ABORTION; THYROID DISEASE;

EID: 79955629366     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111795470895     Document Type: Article

References (64)

1. Okosieme, O.E.; Marx, H.; Lazarus, J.H. Medical management of thyroid dysfunction in pregnancy and the postpartum. Expert Opin. Pharmacother., 2008, 9(13), 2281-2293.
2. Lazarus, J.H. Thyroid disorders associated with pregnancy: etiology, diagnosis, and management. Treat. Endocrinol., 2005, 4(1), 31-41.
3. Laurberg, P.; Bournaud, C.; Karmisholt, J.; Orgiazzi, J. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur. J. Endocrinol., 2009, 160(1), 1-8.
4. Fantz, C.R.; Dagogo-Jack, S.; Ladenson, J.H.; Gronowski, A.M. Thyroid function during pregnancy. Clin. Chem., 1999, 45(12), 2250-2258.
5. Chan, S.; Rovet, J. Thyroid hormones in fetal central nervous system development. Fetal Matern. Med. Rev., 2003, 14(3), 177-208.
6. Gärtner, R. Thyroid disorders during pregnancy. Dtsch. Med. Wochenschr., 2009, 134(3), 83-86.
7. Lazarus, J.H.; Premawardhana, L.D. Screening for thyroid disease in pregnancy. J. Clin. Pathol., 2005, 58(5), 449-452.
8. Cooper, D.S. Hyperthyroidism. Lancet, 2003, 362(9382), 459-468.
9. Cooper, D.S. Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies. J. Clin. Endocrinol. Metab., 2003, 88(8), 3474-3481.
10. Cooper, D.S. Antithyroid drugs. N. Eng. J. Med., 2005, 352(9), 905-917.
11. Zoeller, R.T.; Crofton, K.M. Mode of action: developmental thyroid hormone insufficiency-neurological abnormalities resulting from exposure to propylthiouracil. Crit. Rev. Toxicol., 2005, 35(8-9), 771-781.
12. Sonnet, E.; Massart, C.; Gibassier, J.; Allannic, H.; Maugendre, D. Longitudinal study of soluble intercellular adhesion molecule-1 (ICAM-1) in sera of patients with Graves' disease. J. Endocrinol. Invest., 1999, 22(6), 430-435.
13. Mitsiades, N.; Poulaki, V.; Tseleni-Balafouta, S.; Chrousos, G.P.; Koutras, D.A. Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease. Thyroid, 2000, 10(7), 527-532.
14. Zantut-Wittmann, D.E.; Tambascia, M.A.; da Silva Trevisan, M.A.; Pinto, G.A.; Vassallo, J. Antithyroid drugs inhibit in vivo HLA-DR expression in thyroid follicular cells in Graves' disease. Thyroid, 2001, 11(6), 575-580.
15. Volpé, R. The immunomodulatory effects of anti-thyroid drugs are mediated via actions on thyroid cells, affecting thyrocyteimmunocyte signalling: a review. Curr. Pharm. Des., 2001, 7(6), 451-460.
16. Cooper, D.S. The side effects of antithyroid drugs. Endocrinologist, 1999, 9(6), 457-467.
17. Tajiri, J.; Noguchi, S. Antithyroid drug-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis. Thyroid, 2004, 14(6), 459-462.
18. Pearce, S.H. Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK. Clin. Endocrinol. (Oxf)., 2004, 61(5), 589-594.
19. Ruiz, J.K.; Rossi, G.V.; Vallejos, H.A.; Brenet, R.W.; Lopez, I.B.; Escribano, A.A. Fulminant hepatic failure associated with propylthiouracil. Ann. Pharmacother., 2003, 37(2), 224-228.
20. Russo, M.W.; Galanko, J.A.; Shrestha, R.; Fried, M.W.; Watkins, P. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl., 2004, 10(8), 1018-1023.
21. Arab, D.M.; Malatjalian, D.A.; Rittmaster, R.S. Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole. J. Clin. Endocrinol. Metab., 1995, 80(4), 1083-1085.
22. Sera, N.; Ashizawa, K.; Ando, T.; Abe, Y.; Ide, A.; Usa, T.; Tominaga, T.; Ejima, E.; Yokoyama, N.; Eguchi, K. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease. Thyroid, 2000, 10(7), 595-599.
23. Marchant, B.; Brownlie, B.E.; Hart, D.M.; Horton, P.W.; Alexander, W.D. The placental transfer of propylthiouracil, methimazole and carbimazole. J. Clin. Endocrinol. Metab., 1977, 45(6), 1187-1193.
24. Atkins, P.; Cohen, S.B.; Phillips, B.J. Drug therapy for hyperthyroidism in pregnancy: safety issues for mother and fetus. Drug Saf., 2000, 23(3), 229-244.
25. Mortimer, R.H.; Cannell, G.R.; Addison, R.S.; Johnson, L.P.; Roberts, M.S.; Bernus, I. Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J. Clin. Endocrinol. Metab., 1997, 82(9), 3099-3102.
26. Sitar, D.S.; Abu-Bakare, A.; Gardiner, R.J. Propylthiouracil disposition in pregnant and post-partum women. Pharmacology, 1982, 25(1), 57-60.
27. Koibuchi, N.; Chin, W.W. Thyroid hormone action and brain development. Trends Endocrinol. Metab., 2000, 11(4), 123-128.
28. Singh, R.; Upadhyay, G.; Kumar, S.; Kapoor, A.; Kumar, A.; Tiwari, M.; Godbole, M.M. Hypothyroidism alters the expression of Bcl-2 family genes to induce enhanced apoptosis in the developing cerebellum. J. Endocrinol., 2003, 176(1), 39-46.
29. Gravel, C.; Sasseville, R.; Hawkes, R. Maturation of the corpus callosum of the rat: II. Influence of thyroid hormones on the number and maturation of axons. J. Comp. Neurol., 1990, 291(1), 147-161.
30. Madeira, M.D.; Azevedo, F.P.; Paula-Barbosa, M.M. Effects of long-term hypothyroidism in the morphology and synaptic organization of cerebellar ectopic granule cells. Histol. Histopathol., 1988, 3(4), 351-359.
31. Friedland, D.R.; Rothschild, M.A. Rapid resolution of fetal goiter associated with maternal Grave's disease: a case report. Int. J. Pediatr. Otorhinolaryngol., 2000, 54(1), 59-62.
32. Ochoa-Maya, M.R.; Frates, M.C.; Lee-Parritz, A.; Seely, E.W. Resolution of fetal goiter after discontinuation of propylthiouracil in a pregnant woman with Graves' hyperthyroidism. Thyroid, 1999, 9(11), 1111-1114.
33. Azizi, F.; Khamseh, M.E.; Bahreynian, M.; Hedayati, M. Thyroid function and intellectual development of children of mothers taking methimazole during pregnancy. J. Endocrinol. Invest., 2002, 25(7), 586-589.
34. Wing, D.A.; Millar, L.K.; Koonings, P.P.; Montoro, M.N.; Mestman, J.H. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am. J. Obstet. Gynecol., 1994, 170(1 Pt 1), 90-95.
35. Di Gianantonio, E.; Schaefer, C.; Mastroiacovo, P.P.; Cournot, M.P.; Benedicenti, F.; Reuvers, M.; Occupati, B.; Robert, E.; Bellemin, B.; Addis, A.; Arnon, J.; Clementi, M. Adverse effects of prenatal methimazole exposure. Teratology, 2001, 64(5), 262-266.
36. Momotani, N.; Ito, K.; Hamada, N.; Ban, Y.; Nishikawa, Y.; Mimura, T. Maternal hyperthyroidism and congenital malformation in the offspring. Clin. Endocrinol. (Oxf.), 1984, 20(6), 695-700.
37. Cheron, R.G.; Kaplan, M.M.; Larsen, P.R.; Selenkow, H.A.; Crigler, J.F. Jr. Neonatal thyroid function after propylthiouracil therapy for maternal Graves' disease. N. Engl. J. Med., 1981, 304(9), 525-528.
38. Karlsson, F.A.; Axelsson, O.; Melhus, H. Severe embryopathy and exposure to methimazole in early pregnancy. J. Clin. Endocrinol. Metab., 2002, 87(2), 947-949.
39. Eisenstein, Z.; Weiss, M.; Katz, Y.; Bank, H. Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero. Eur. J. Pediatr., 1992, 151(8), 558-559.
40. Messer, P.M.; Hauffa, B.P.; Olbricht, T.; Benker, G.; Kotulla, P.; Reinwein, D. Antithyroid drug treatment of Graves' disease in pregnancy: long-term effects on somatic growth, intellectual development and thyroid function of the offspring. Acta Endocrinol. (Copenh.), 1990, 123(3), 311-316.
41. Davis, L.E.; Leveno, K.J.; Cunningham, F.G. Hypothyroidism complicating pregnancy. Obstet. Gynecol., 1988, 72(1), 108-112.
42. Casey, B.M.; Dashe, J.S.; Wells, C.E.; McIntire, D.D.; Byrd, W.; Leveno, K.J.; Cunningham, F.G. Subclinical hypothyroidism and pregnancy outcomes. Obstet. Gynecol., 2005, 105(2), 239-245.
43. Stagnaro-Green, A.; Chen, X.; Bogden, J.D.; Davies, T.F.; Scholl, T.O. The thyroid and pregnancy: a novel risk factor for very preterm delivery. Thyroid, 2005, 15(4), 351-357.
44. McClain, M.R.; Lambert-Messerlian, G.; Haddow, J.E.; Palomaki, G.E.; Canick, J.A.; Cleary-Goldman, J.; Malone, F.D.; Porter, T.F.; Nyberg, D.A.; Bernstein, P.; D'Alton, M.E.; FaSTER Research Consortium. Sequential first-and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study. Am. J. Obstet. Gynecol., 2008, 199(2), 129. e1-e6.
45. Mandel, S.J.; Brent, G.A.; Larsen, P.R. Levothyroxine therapy in patients with thyroid disease. Ann. Intern. Med., 1993, 119(6), 492-502.
46. Abalovich, M.; Amino, N.; Barbour, L.A.; Cobin, R.H.; de Groot, L.J.; Glinoer, D.; Mandel, S.J.; Stagnaro-Green, A. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab., 2007, 92(8), S1-S47.
47. Alexander, E.K. Thyroid function: the complexity of maternal hypothyroidism during pregnancy. Nat. Rev. Endocrinol., 2009, 5(9), 480-481.
48. Haddow, J.E.; Palomaki, G.E.; Allan, W.C.; Williams, J.R.; Knight, G.J.; Gagnon, J.; O'Heir, C.E.; Mitchell, M.L.; Hermos, R.J.; Waisbren, S.E.; Faix, J.D.; Klein, R.Z. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N. Engl. J. Med., 1999, 341(8), 549-555.
49. Pop, V.J.; Kuijpens, J.L.; van Baar, A.L.; Verkerk, G.; van Son, M.M.; de Vijlder, J.J.; Vulsma, T.; Wiersinga, W.M.; Drexhage, H.A.; Vader, H.L. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin. Endocrinol. (Oxf), 1999, 50(2), 149-155.
50. Pop, V.J.; Brouwers, E.P.; Vader, H.L.; Vulsma, T.; van Baar, A.L.; de Vijlder, J.J. Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3-year follow-up study. Clin. Endocrinol. (Oxf), 2003, 59(3), 282-288.
51. Mandel, S.J.; Larsen, P.R.; Seely, E.W.; Brent, G.A. Increased need for thyroxine during pregnancy in women with primary hypothyroidism. N. Engl. J. Med., 1990, 323(2), 91-96.
52. Alexander, E.K.; Marqusee, E.; Lawrence, J.; Jarolim, P.; Fischer, G.A.; Larsen, P.R. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N. Eng. J. Med., 2004, 351(3), 241-249.
53. Roti, E.; Fang, S.L.; Green, K.; Emerson, C.H.; Braverman, L.E. Human placenta is an active site of thyroxine and 3,3'5-triiodothyronine tyrosyl ring deiodination. J. Clin. Endocrinol. Metab., 1981, 53(3), 498-501.
54. Bell, G.M.; Sawers, J.S.; Forfar, J.C.; Doig, A.; Toft, A.D. The effect of minor increments in plasma thyroxine on heart rate and urinary sodium excretion. Clin. Endocrinol. (Oxf), 1983, 18(5), 511-516.
55. Robson, S.C. Fetal drug therapy. Curr. Obstet. Gynaecol., 1995, 5(4), 230-238.
56. Li, H.; Richard, K.; McKinnon, B.; Mortimer, R.H. Effect of iodide on human choriogonadotropin, sodium-iodide symporter expression, and iodide uptake in BeWo choriocarcinoma cells. J. Clin. Endocrinol. Metab., 2007, 92(10), 4046-4051.
57. Clark, S.M.; Saade, G.R.; Snodgrass, W.R.; Hankins, G.D. Pharmacokinetics and pharmacotherapy of thionamides in pregnancy. Ther. Drug Monit., 2006, 28(4), 477-483.
58. Burrow, G.H. Thyroid status in normal pregnancy. J. Clin. Endocrinol. Metab., 1990, 71(2), 274-275.
59. Becks, G.P.; Burrow, G.N. Thyroid disease and pregnancy. Med. Clin. North Am., 1991, 75(1), 121-150.
60. El-Zaheri, M.M.; Vagenakis, A.G.; Hinerfeld, L.; Emerson, C.H.; Braverman, L.E. Maternal thyroid function is the major determinant of amniotic fluid 3,3',5'-triiodothyronine in the rat. J. Clin. Invest., 1981, 67(4), 1126-1133.
61. Gardner, D.F.; Cruikshank, D.P.; Hays, P.M.; Cooper, D.S. Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests. J. Clin. Endocrinol. Metab. 1986, 62(1), 217-220.
62. Malkawi, O.M. Thyroid disease and pregnancy. Saudi Med. J., 2002, 23(6), 633-639.
63. Brent, G.A. Maternal hypothyroidism: recognition and management. Thyroid, 1999, 9(7), 661-665.
64. Harborne, L.R.; Alexander, C.E.; Thomson, A.J.; O'Reilly, D.J.; Greer, I.A. Outcomes of pregnancy complicated by thyroid disease. Aust. N. Z. J. Obstet. Gynaecol., 2005, 45(3), 239-242.